Betamethasone Sodium Phosphate

CAS 151-73-5 5 current records 4 historicalSmall Molecule

Who holds supplier records for Betamethasone Sodium Phosphate? 5 organisations hold a current record for Betamethasone Sodium Phosphate: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Spain (1), Portugal (1), India (1) and Malaysia (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Betamethasone Sodium Phosphate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/betamethasone-sodium-phosphate

Reading the evidence

  • 5 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (5)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Betamethasone Sodium Phosphate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Spain1Portugal1India1Malaysia1Country not recorded for 1
Need Betamethasone Sodium Phosphate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (3)

Certificates of Suitability on the EDQM register for Betamethasone Sodium Phosphate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 5 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
CURIA SPAIN S.A.U. BoecilloES
CEP 2025-201 - Rev 01
Betamethasone sodium phosphate, Process III
Mar 2026Inspected Feb 2026
Spain
HENAN LIHUA PHARMACEUTICAL CO., LTD. AnyangCN
CEP 2023-440 - Rev 00
Betamethasone sodium phosphate
May 2025—
SYMBIOTICA SPECIALITY INGREDIENTS SDN. BHD. PeraiMY
R1-CEP 2013-326 - Rev 00
Betamethasone sodium phosphate
Oct 2020—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Betamethasone Sodium Phosphate are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • India · Inactive DMF 22646 · filed Dec 2008
  • CRYSTAL PHARMA SAU
    Inactive DMF 17803 · filed Nov 2004
  • HOECHST MARION ROUSSEL SA
    Inactive DMF 10423 · filed Aug 1993
  • COMPANIA ESPANOLA DE SINTESIS QUIMICA SA
    Inactive DMF 6727 · filed Nov 1986

Overview

Betamethasone Sodium Phosphate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200762).

Chemical identity

IUPAC name
disodium;[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate
Canonical SMILES
C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]
InChIKey
PLCQGRYPOISRTQ-LWCNAHDDSA-L
Synonyms
Betamethasone 21-phosphate disodium salt, Betamethasone disodium phosphate, Betamethasone sodium phosphate, Betamethasone sodium phosphate component of celestone soluspan, Betam-ophtal, Betnesol, Betnesol-n, Celestone, NSC-90616, Vistamethasone, Vistamethasone n, Betamethasone 21-disodium phosphate

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Betamethasone Sodium Phosphate?

5 organisations hold an active US FDA Type II Drug Master File or a CEP for Betamethasone Sodium Phosphate: CURIA SPAIN SAU (Spain), HENAN LIHUA PHARMACEUTICAL CO LTD, Hovione FarmaCiencia SA (Portugal), SYMBIOTEC PHARMALAB PRIVATE LTD (India) and SYMBIOTICA SPECIALITY INGREDIENTS SDN BHD (Malaysia). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Betamethasone Sodium Phosphate Drug Master Files are active?

CURIA SPAIN SAU (DMF 38831), HENAN LIHUA PHARMACEUTICAL CO LTD (DMF 39257), Hovione FarmaCiencia SA (DMF 6687) and SYMBIOTEC PHARMALAB PRIVATE LTD (DMF 37466). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Betamethasone Sodium Phosphate records mean?

4 organisations have only inactive Type II DMFs for Betamethasone Sodium Phosphate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Betamethasone Sodium Phosphate have a European Certificate of Suitability?

Yes. 3 organisations hold a valid CEP for Betamethasone Sodium Phosphate on the EDQM register, including CURIA SPAIN S.A.U. Boecillo (ES), HENAN LIHUA PHARMACEUTICAL CO., LTD. Anyang (CN) and SYMBIOTICA SPECIALITY INGREDIENTS SDN. BHD. Perai (MY). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Betamethasone Sodium Phosphate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Betamethasone Sodium Phosphate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.